139 related articles for article (PubMed ID: 16298692)
21. On the potential of thioredoxin reductase inhibitors for cancer therapy.
Urig S; Becker K
Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
[TBL] [Abstract][Full Text] [Related]
22. Curcumin targeting the thioredoxin system elevates oxidative stress in HeLa cells.
Cai W; Zhang B; Duan D; Wu J; Fang J
Toxicol Appl Pharmacol; 2012 Aug; 262(3):341-8. PubMed ID: 22634334
[TBL] [Abstract][Full Text] [Related]
23. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.
Cassidy PB; Edes K; Nelson CC; Parsawar K; Fitzpatrick FA; Moos PJ
Carcinogenesis; 2006 Dec; 27(12):2538-49. PubMed ID: 16777982
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events.
Rundlöf AK; Arnér ES
Antioxid Redox Signal; 2004 Feb; 6(1):41-52. PubMed ID: 14980055
[TBL] [Abstract][Full Text] [Related]
25. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation.
Nalvarte I; Damdimopoulos AE; Nystöm C; Nordman T; Miranda-Vizuete A; Olsson JM; Eriksson L; Björnstedt M; Arnér ES; Spyrou G
J Biol Chem; 2004 Dec; 279(52):54510-7. PubMed ID: 15471857
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds.
Branco V; Godinho-Santos A; Gonçalves J; Lu J; Holmgren A; Carvalho C
Free Radic Biol Med; 2014 Aug; 73():95-105. PubMed ID: 24816296
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of thioredoxin reductase induces apoptosis in neuronal cell lines: role of glutathione and the MKK4/JNK pathway.
Seyfried J; Wüllner U
Biochem Biophys Res Commun; 2007 Aug; 359(3):759-64. PubMed ID: 17559804
[TBL] [Abstract][Full Text] [Related]
29. Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition.
Nalvarte I; Damdimopoulos AE; Spyrou G
Free Radic Biol Med; 2004 May; 36(10):1270-8. PubMed ID: 15110392
[TBL] [Abstract][Full Text] [Related]
30. Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism.
Biterova EI; Turanov AA; Gladyshev VN; Barycki JJ
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15018-23. PubMed ID: 16217027
[TBL] [Abstract][Full Text] [Related]
31. [Reactive oxygen species in regulation of cell migration. The role of thioredoxin reductase].
Sroka J; Madeja Z
Postepy Biochem; 2009; 55(2):145-52. PubMed ID: 19824470
[TBL] [Abstract][Full Text] [Related]
32. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation.
Cox AG; Brown KK; Arner ES; Hampton MB
Biochem Pharmacol; 2008 Oct; 76(9):1097-109. PubMed ID: 18789312
[TBL] [Abstract][Full Text] [Related]
33. Stress-dependent regulation of the gene encoding thioredoxin reductase from the fission yeast.
Hong SM; Lim HW; Kim IH; Kim K; Park EH; Lim CJ
FEMS Microbiol Lett; 2004 May; 234(2):379-85. PubMed ID: 15135546
[TBL] [Abstract][Full Text] [Related]
34. Thioredoxin-linked metabolism in Entamoeba histolytica.
Arias DG; Gutierrez CE; Iglesias AA; Guerrero SA
Free Radic Biol Med; 2007 May; 42(10):1496-505. PubMed ID: 17448896
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
[TBL] [Abstract][Full Text] [Related]
36. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
37. Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization.
Miranda-Vizuete A; Damdimopoulos AE; Pedrajas JR; Gustafsson JA; Spyrou G
Eur J Biochem; 1999 Apr; 261(2):405-12. PubMed ID: 10215850
[TBL] [Abstract][Full Text] [Related]
38. Effects of the antioxidant Pycnogenol on cellular redox systems in U1285 human lung carcinoma cells.
Gandin V; Nyström C; Rundlöf AK; Jönsson-Videsäter K; Schönlau F; Hörkkö J; Björnstedt M; Fernandes AP
FEBS J; 2009 Jan; 276(2):532-40. PubMed ID: 19077163
[TBL] [Abstract][Full Text] [Related]
39. Genomic organization and identification of a novel alternative splicing variant of mouse mitochondrial thioredoxin reductase (TrxR2) gene.
Miranda-Vizuete A; Spyrou G
Mol Cells; 2002 Jun; 13(3):488-92. PubMed ID: 12132591
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning of mouse thioredoxin reductases.
Kawai H; Ota T; Suzuki F; Tatsuka M
Gene; 2000 Jan; 242(1-2):321-30. PubMed ID: 10721726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
